Ilan has 15+ years of senior management and operational experience built on strong people skills, and common sense. Previous experiences includes CEO of a cancer diagnostics lab, COO of a $100M multi-national public company, and VP of Operations at a multi-billion dollar hedge fund. Working in both entrepreneurial, and public company operations, Ilan understands people, operations, sales, marketing, finance & legal - and their inter-dependence.

Gil is a seasoned finance executive, with over 15 years of experience in financing start-up and health care institutions, as well as corporate turnarounds and restructurings at private equity fund. Holds an MBA from NYU and BA from UCLA.

Dr. Braddock received his MD/PhD degree from the University of Chicago, was trained in Anatomic Pathology at the NIH, and has been on the faculty of Yale since 2004 where his primary clinical focus is Hematopathology. He is currently an Associate Professor of Pathology at Yale, where he directs an independent laboratory focused on the structural elucidation of proteins and protein complexes that drive hematopoietic disorders.

Dr. Sklar is a tenured faculty at Yale University. He holds a BA from Haverford College, an MD and Ph.D. from Yale University, a Post-doctorate fellowship in Biochemistry at Stanford University, and a MA from Harvard University. Dr. Sklar is a pioneer and one of the world leading thinkers in the area of molecular genetics. He has developed several tests that are standard protocol of testing within pathology diagnostics laboratories.

S. David Hudnall is Professor of Pathology and Laboratory Medicine, and Director of Hematopathology at Yale University School of Medicine. Dr. Hudnall attended medical school at the Medical University of South Carolina in Charleston, SC (1974-78). Following his medical training, Dr. Hudnall completed his residency in Anatomic and Clinical Pathology at the Yale-New Haven Hospital, Yale University School of Medicine (1978-82). This training was fol